Page last updated: 2024-11-12

correolide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

correolide: from Costa Rican tree, Spachea correae; selectively inhibits voltage-gated potassium channel Kv1.3 in human T lymphocytes by membrane depolarization [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
Spacheagenus[no description available]MalpighiaceaeA plant family of the order Polygalales, subclass Rosidae class, Magnoliopsida that are mostly shrubs and small trees. Many of the members contain indole alkaloids.[MeSH]

Cross-References

ID SourceID
PubMed CID11643509
CHEBI ID34654
MeSH IDM0304017

Synonyms (6)

Synonym
gtpl2555
correolide
C13849 ,
CHEBI:34654
methyl (1s,2r,3s,4r,5r,6s,8r,11r,12r,15s,16s,22r,23r,24s)-3,4,23,24-tetraacetyloxy-22-(1-acetyloxyethyl)-11-hydroxy-2,5,15-trimethyl-9-methylidene-19-oxo-7,20-dioxahexacyclo[13.9.0.02,12.05,11.06,8.016,22]tetracos-17-ene-6-carboxylate
Q27076888

Research Excerpts

Overview

Correolide is a novel immunosuppressant that inhibits the voltage-gated potassium channel K(v)1.3.

ExcerptReferenceRelevance
"Correolide is a novel immunosuppressant that inhibits the voltage-gated potassium channel K(v)1.3 [Felix et al. "( Binding of correolide to the K(v)1.3 potassium channel: characterization of the binding domain by site-directed mutagenesis.
Bordallo, C; Durand, DJ; Felix, JP; Gao, YD; Garcia, ML; Green, B; Hanner, M; Kaczorowski, GJ; Kohler, M; Linde, AR; Matyskiela, M; Schmalhofer, WA, 2001
)
2.14

Actions

ExcerptReferenceRelevance
"Correolide displays marked selectivity against numerous receptors and voltage- and ligand-gated ion channels."( Identification and biochemical characterization of a novel nortriterpene inhibitor of the human lymphocyte voltage-gated potassium channel, Kv1.3.
Bao, JM; Borris, R; Bugianesi, RM; Felix, JP; Garcia, ML; Goetz, MA; Hensens, OD; Kaczorowski, GJ; Kayser, F; Parsons, WH; Rupprecht, K; Schmalhofer, WA; Slaughter, RS, 1999
)
1.02

Dosage Studied

ExcerptRelevanceReference
" Two compounds were dosed orally, iv, or im, and both compounds suppressed DTH responses, demonstrating that small molecule blockers of Kv1."( Correolide and derivatives are novel immunosuppressants blocking the lymphocyte Kv1.3 potassium channels.
Baker, R; Bao, J; Blake, JT; Boltz, RC; Cunningham, P; Dumont, F; Feeney, W; Fischer, P; Goetz, MA; Hora, D; Ita, IE; Kaczorowski, G; Kayser, F; Koo, GC; McManus, OB; Parsons, WH; Pivnichny, J; Rupprecht, KM; Sanchez, M; Shah, K; Sirotina-Meisher, A; Staruch, MJ; Tong, XC; Vincent, S; Wunderler, D, 1999
)
1.75
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
hydroxy steroid
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1346697Human Kv1.3 (Voltage-gated potassium channels)1999Biochemistry, Apr-20, Volume: 38, Issue:16
Identification and biochemical characterization of a novel nortriterpene inhibitor of the human lymphocyte voltage-gated potassium channel, Kv1.3.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (25)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's3 (12.00)18.2507
2000's18 (72.00)29.6817
2010's4 (16.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.57

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.57 (24.57)
Research Supply Index3.26 (2.92)
Research Growth Index4.83 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.57)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (8.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other23 (92.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]